Studies have proved that FTO is not only limited to playing a major role in obesity-related diseases, but is also involved in the occurrence, development, and prognosis of a variety of cancers, including AML, glioblastoma, and breast cancer (Chen and Du, 2019; Lan et al., 2020). This evidence concerns the gene FTO and acute myeloid leukemia.